Ranbaxy Q4 net up 166% at Rs 185 cr

Ranbaxy Laboratories, the country's largest pharma company, on Thursday said its fourth quarter net profit more than doubled to Rs 185.59 crore.

This is a rise of 166 per cent over the net profit of Rs 69.6 crore in the corresponding October-December quarter last fiscal.Consolidated sales for the last quarter grew by 22 per cent to Rs 1,707.7 crore compared to Rs 1,405.5 crore during the same period last year.